AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through

Matteo Caforio1, Nicola Tumino2, Cristina Sorino3

  • 1Department of Pediatric Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Rome, Italy.

PubMed
Abstract

Insights

The transcription factor Che-1 (AATF) over-expression in tumors impairs NK-cell anti-tumor immunity by down-regulating Nectin-1, affecting cancer cell recognition and killing. Targeting Che-1 may restore immune function against tumors.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • AATF/Che-1 is over-expressed in tumors, influencing proliferation and viability.
  • Its impact on the anti-tumor immune response remains largely uninvestigated.

Purpose of the Study:

  • To investigate the role of Che-1 in modulating the anti-tumor immune response.
  • To determine how Che-1 affects Natural Killer (NK) cell activity in the context of solid tumors.

Main Methods:

  • ChIP-sequencing to identify Che-1 binding sites.
  • Co-culture experiments with NK cells and tumor cells with altered Che-1 expression.
  • Flow cytometry to analyze NK cell receptors and tumor ligand expression.

Main Results:

  • Che-1 modulates Nectin-1 ligand expression transcriptionally, impairing NK cell killing activity.
  • Down-regulation of Nectin-1 by Che-1 alters NK cell ligand expression, affecting activation.
  • NK cells from Che-1 transgenic mice show reduced activating receptor expression and impaired function.

Conclusions:

  • Che-1 over-expression disrupts the balance between NK cell receptors and tumor ligands, hindering anti-tumor immunity.
  • Che-1 acts as a regulator of anti-tumor immunity, with a dual role in cancer promotion and immune modulation.
  • Targeting Che-1 is a potential therapeutic strategy to enhance anti-tumor immune responses.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
985
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K